Dermata Therapeutics Management
Management criteria checks 3/4
Dermata Therapeutics' CEO is Gerry Proehl, appointed in Dec 2014, has a tenure of 9.42 years. total yearly compensation is $392.00K, comprised of 71.4% salary and 28.6% bonuses, including company stock and options. directly owns 2.97% of the company’s shares, worth $64.82K. The average tenure of the management team and the board of directors is 8.6 years and 2.8 years respectively.
Key information
Gerry Proehl
Chief executive officer
US$392.0k
Total compensation
CEO salary percentage | 71.4% |
CEO tenure | 9.4yrs |
CEO ownership | 3.0% |
Management average tenure | 8.6yrs |
Board average tenure | 2.8yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$392k | US$280k | -US$8m |
Sep 30 2023 | n/a | n/a | -US$7m |
Jun 30 2023 | n/a | n/a | -US$8m |
Mar 31 2023 | n/a | n/a | -US$9m |
Dec 31 2022 | US$506k | US$318k | -US$10m |
Sep 30 2022 | n/a | n/a | -US$10m |
Jun 30 2022 | n/a | n/a | -US$12m |
Mar 31 2022 | n/a | n/a | -US$11m |
Dec 31 2021 | US$1m | US$136k | -US$10m |
Sep 30 2021 | n/a | n/a | -US$8m |
Jun 30 2021 | n/a | n/a | -US$5m |
Mar 31 2021 | n/a | n/a | -US$4m |
Dec 31 2020 | US$27k | US$27k | -US$3m |
Compensation vs Market: Gerry's total compensation ($USD392.00K) is below average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Gerry's compensation has been consistent with company performance over the past year.
CEO
Gerry Proehl (64 yo)
9.4yrs
Tenure
US$392,000
Compensation
Mr. Gerald T. Proehl, also known as Gerry, is Co-founded at Dermata Therapeutics, Inc. He has been the Chief Executive Officer and President of Dermata Therapeutics, Inc. since December 2014, Chairman sinc...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 9.4yrs | US$392.00k | 2.97% $ 64.8k | |
Co-Founder & Lead Independent Director | no data | US$73.00k | 0.12% $ 2.5k | |
Senior VP & CFO | 2.7yrs | US$442.25k | 0% $ 0 | |
Senior VP & Chief Development Officer | 8.9yrs | US$469.97k | 0.026% $ 563.2 | |
Senior Director of Legal & Business Development | no data | no data | no data | |
Senior Vice President of Regulatory Affairs & Quality Assurance | 8.3yrs | US$27.04k | no data |
8.6yrs
Average Tenure
64yo
Average Age
Experienced Management: DRMA's management team is seasoned and experienced (8.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 3.1yrs | US$392.00k | 2.97% $ 64.8k | |
Co-Founder & Lead Independent Director | 9.4yrs | US$73.00k | 0.12% $ 2.5k | |
Independent Director | 2.8yrs | US$44.00k | 0% $ 0 | |
Independent Director | 7.7yrs | US$50.00k | 0.059% $ 1.3k | |
Independent Director | 2.8yrs | US$55.00k | 0.028% $ 604.4 | |
Independent Director | 2.8yrs | US$47.50k | 0.022% $ 479.1 | |
Independent Director | 2.8yrs | US$49.00k | 0.023% $ 494.1 | |
Independent Director | 2.3yrs | US$47.50k | 0.022% $ 479.1 |
2.8yrs
Average Tenure
64yo
Average Age
Experienced Board: DRMA's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.